Navigation Links
Horizon Therapeutics Presents Phase 3 Study Results Identifying Risk Factors for Ulcer Development Among NSAID Users
Date:10/26/2009

t treatment option."

About HZT-501

HZT-501 is a novel, proprietary fixed-dose tablet combining the most prescribed NSAID in the U.S., ibuprofen, with a high dose of the most potent H2 antagonist, famotidine, in a single pill. It is anticipated that HZT-501 will provide effective pain relief and reduce stomach acidity during the peak time of ulceration risk, thus reducing the risk of NSAID-associated upper GI ulcers.

About the Arthritis and Pain Market

According to the Arthritis Foundation, arthritis affects 46 million people in the U.S. and costs the U.S. economy $128 billion annually. According to a study by the Centers for Disease Control and Prevention (CDC) for the National Arthritis Data Workgroup, due to the increasing aging population, arthritis is projected to increase by 40 percent in the next two decades. The CDC estimates that 67 million people will be affected by arthritis by 2030. Additionally, chronic pain affects an estimated 86 million American adults. NSAIDs are among the most widely used drugs in the world for the treatment of arthritis and pain and are a major cause of GI complications, including ulcers. NSAIDs block enzymes and reduce prostaglandins throughout the body and as a consequence, ongoing inflammation, pain, and fever are reduced. Because the prostaglandins that protect the stomach are reduced, NSAIDs often cause ulcers in the stomach. NSAID-induced GI toxicity causes an estimated 16,500 deaths and more than 107,000 hospitalizations annually in the U.S. alone.

If deaths from the gastrointestinal effects of NSAIDs were tabulated separately in the National Vital Statistics reports, these effects would equate to the 15th most common cause of death in the U.S. Studies have shown that less than 30 percent of high-risk NSAID patients are co-prescribed a gastro-protective agent in combination with their NSAID. In addition, patient adherence to a regimen of separ
'/>"/>

SOURCE Horizon Therapeutics, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Horizon Therapeutics HZT-501 Significantly Reduces Incidence of NSAID-Induced Upper Gastrointestinal Ulcers in Patients With Mild-to-Moderate Pain
2. Boston Scientific Welcomes Publication of HORIZONS AMI Trial Results in New England Journal of Medicine
3. Horizon Therapeutics Announces Two Pivotal HZT-501 Phase 3 Trials Meet Primary Endpoints
4. HORIZONS AMI Trial Demonstrates Superior Outcomes with TAXUS(R) Drug-Eluting Stents in Heart Attack Patients
5. Horizon Therapeutics Completes Enrollment in Phase 3 Trials for Lead Product Candidate HZT-501
6. GlaxoSmithKline and Theravance Announce Start of Large Phase 2B ICS and LABA Studies for Asthma in the Horizon Program
7. Horizon Therapeutics Initiates Long-Term Phase 3 Safety Study for Lead Product Candidate HZT-501
8. Inhibikase Therapeutics Discusses New Platform for Infectious Disease Pharmaceuticals at BIOCOM 2009
9. Cell Therapeutics, Inc. (CTI) to Present at 8th Annual BIO Investor Forum
10. Cell Therapeutics, Inc. Reports Outcome of Annual Meeting of Shareholders
11. Logical Therapeutics to Present Data on LT-NS001 at American College of Gastroenterology Annual Meeting
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/29/2014)... , Aug. 29, 2014 The Competitive Intelligence ... and marketplace changes. CI leaders who adjust will succeed, ... In a new Best Practices, LLC study CI leaders ... insights, including: - Use secondary research whenever ... research - Internal staff who are creative ...
(Date:8/29/2014)... Aug. 29, 2014   Mast Therapeutics, Inc. ... announced today that Santosh Vetticaden, Chief Medical Officer ... Company, for personal reasons, in mid-September.  Edwin ... of Aires Pharmaceuticals, which Mast acquired earlier this ... the Company,s interim Chief Medical Officer.  Dr. Parsley ...
(Date:8/29/2014)... 2014 Research and Markets has ... Industry Report, 2014-2017" report to their offering. ... proportion of reimbursement for medical expenses, the Chinese orthopedic ... scale presenting a CAGR of 19.2% during 2009-2013. Trauma ... segments of orthopedic instruments in China ...
Breaking Medicine Technology:Using the Competitive Intelligence Function to Drive Better Business Decisions in the Pharmaceutical Sector 2Mast Therapeutics Announces Management Change 2Mast Therapeutics Announces Management Change 3Mast Therapeutics Announces Management Change 4China Orthopedic Instrument Industry Report, 2014-2017 2
... Technology, Inc. announced today that Joe Chaudoin and Chris ... Vice President of Sales for the Eastern and Western ... Joe Chaudoin has over 20 years of ... career at Codman and Ethicon-Endo Surgery (both Johnson & ...
... HILLS, Calif., Jan. 19, 2012  HealthTech Capital announced today ... A2 investor in Cadence Biomedical, Inc. The move underscores ... to fund innovative, early-stage companies. Other investors included Alliance ... Angels, and Wings. With a first close of $750,000 ...
Cached Medicine Technology:Zyga Technology, Inc. Makes Two Key Additions to the Sales Leadership Team 2HealthTech Capital Leads Series A2 With Over $300,000 Investment in Cadence Biomedical 2
(Date:8/30/2014)... 2014 Top10BestSEOHosting.com is a well-known ... announced that HostGator.com http://secure.hostgator.com/~affiliat/cgi-bin/affiliates/clickthru.cgi?id=seohosts is the ... Also, they has announced that Bluehost and Arvixe ... Hostgator, one of the Top 10 Web Hosting ... Windows hosting, and it offers rich features and ...
(Date:8/30/2014)... Astoria, New York (PRWEB) August 30, 2014 ... head, back and shoulder pain in our society and ... as lost production costs, it’s vital that continuing education ... with its goal to help physical therapists help others, ... through September 2nd. , Three learning styles ...
(Date:8/30/2014)... (PRWEB) August 30, 2014 Jake W., 18, ... while in the Back2Basics Outdoor Adventures transition program ... finish high school so I can actually start on a ... and math, and I'm done.” , He has six months ... Back2Basics program. Most clients choose to continue on to the ...
(Date:8/30/2014)... (PRWEB) August 30, 2014 “In 2013, a ... The Jones Firm says in a recently released article on ... person was injured in an auto accident every 12 minutes, ... minutes,” they continue. “Based on the 2013 statistics, between now ... vehicle collision.” , The threat of an auto accident is ...
(Date:8/30/2014)... 2014 Zensah®, the leader in compression technology ... Sleeve . The camo sleeves are the first released as ... The camo line includes classic colors like army green and ... Known as tibial stress syndrome, shin splints cause dull aches ... Swollen and irritated muscles, stress fractures, or over pronation may ...
Breaking Medicine News(10 mins):Health News:Top10BestSEOHosting.com: HostGator.com Is The Best Windows Hosting Supplier 2Health News:Leader in Manual Therapy Continuing Education Makes it Easier for Physical Therapists to Improve Results on Patients 2Health News:Startling Washington Auto Accident Statistics Discussed In Recently Released Article By The Jones Firm 2Health News:Camo Compression Leg Sleeves Provide Shin Splint Relief for Runners 2
... gloss, depth of image, and surface ... Texas, Oct. 22 Solvay Engineered Polymers,Inc., has ... in the,production of extruded sheet. The new ADDHERE(TM) ... layer onto a substrate of thermoplastic,polyolefin (TPO) for ...
... with Top Children,s Miracle Network Health Experts, SALT LAKE CITY, Oct. 22 /PRNewswire/, ... experts from 170 Children,s ... questions about Methicillin-resistant Staphylococcus Aureus ... to antibiotics, and other ...
... Chairman Howard Dean issued the following statement in response,to ... $46 billion,in war spending, for a total of $196 ... coverage to 10 million of America,s low income children:, ... to fund his war of,choice in Iraq but has ...
... There,s no proof cancer will spread to the ... (HealthDay News) -- Women diagnosed with breast cancer who ... other, healthy breast removed as a preventive measure. , ... mastectomy, more than doubled from 1998 to 2003, according ...
... 22 The start of the,patent lawsuit by VNUS(R) ... laser competitors, Diomed, AngioDynamics and Vascular,Solutions, has been delayed ... delay is due to a busy court calendar. A ... new trial start dates. At,the conference, the parties will ...
... 22 Dialysis Corporation,of America (Nasdaq: DCAI ... third,quarter 2007 earnings after the close of the ... of America owns and operates freestanding kidney,hemodialysis centers ... Carolina and Virginia, and provides in-hospital,dialysis services on ...
Cached Medicine News:Health News:New ADDHERE(TM) Adhesive Tie Layer Bonds Acrylic Cap Layers to Substrates of Thermoplastic Polyolefin (TPO) in Production of Sheet for Use in Thermoforming 2Health News:New ADDHERE(TM) Adhesive Tie Layer Bonds Acrylic Cap Layers to Substrates of Thermoplastic Polyolefin (TPO) in Production of Sheet for Use in Thermoforming 3Health News:New ADDHERE(TM) Adhesive Tie Layer Bonds Acrylic Cap Layers to Substrates of Thermoplastic Polyolefin (TPO) in Production of Sheet for Use in Thermoforming 4Health News:Children's Miracle Network Hospital Doctors On Call to Answer Questions About MRSA Infection 2Health News:More Women Choosing 'Preventive' Double Mastectomy 2Health News:More Women Choosing 'Preventive' Double Mastectomy 3Health News:Delay in Start of VNUS Patent Litigation and Court Ruling on Summary Judgment Motion 2Health News:Dialysis Corporation of America Announces Third Quarter 2007 Earnings Release Date 2
The original battery-operated suction and irrigation system features a new ergonomic hand piece and superior performance characteristics that have increased the overall flow rate....
...
...
...
Medicine Products: